Aytu Biopharma Inc (AYTU)
1.2350 -0.0350 (-2.76%) 03/26/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Wed, Mar 26th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,120 | -17,051 | -14,594 | -7,394 | -701 |
| Depreciation Amortization | 1,991 | 9,374 | 7,112 | 7,422 | 2,446 |
| Accounts receivable | -1,684 | -7,153 | -12,335 | -3,834 | -6,212 |
| Accounts payable and accrued liabilities | 946 | 2,384 | N/A | -838 | N/A |
| Other Working Capital | -1,351 | -5,799 | -8,257 | -12,545 | -10,083 |
| Other Operating Activity | 8,007 | 13,116 | 13,580 | 5,601 | 5,402 |
| Operating Cash Flow | $-211 | $-5,129 | $-14,494 | $-11,588 | $-9,148 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -76 | -117 | 38 | 37 | 42 |
| Investing Cash Flow | $-76 | $-117 | $38 | $37 | $42 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -348 | -2,250 | 6,590 | 3,616 | 4,274 |
| Debt Repayment | -2,226 | -4,362 | -4,190 | -2,433 | -327 |
| Common Stock Issued | N/A | 15,575 | 13,012 | 11,573 | 10,416 |
| Other Financing Activity | -160 | -92 | -1,137 | -1,064 | -806 |
| Financing Cash Flow | $-2,734 | $8,871 | $14,275 | $11,692 | $13,557 |
| Beginning Cash Position | 22,985 | 19,360 | 19,360 | 19,360 | 19,360 |
| End Cash Position | 19,964 | 22,985 | 19,179 | 19,501 | 23,811 |
| Net Cash Flow | $-3,021 | $3,625 | $-181 | $141 | $4,451 |
| Free Cash Flow | |||||
| Operating Cash Flow | -211 | -5,129 | -14,494 | -11,588 | -9,148 |
| Free Cash Flow | -211 | -5,129 | -14,494 | -11,588 | -9,148 |